-+ 0.00%
-+ 0.00%
-+ 0.00%
Is Bavarian Nordic (CPSE:BAVA) A Bargain After Its WHO Backed Mpox Stockpile Move?
Share
Listen to the news

Bavarian Nordic (CPSE:BAVA) has put its mpox franchise at the center of global health planning, committing 225,000 MVA-BN doses to a new WHO-backed emergency stockpile to support outbreak response.

The recent WHO stockpile announcement lands at a time when momentum in Bavarian Nordic shares has been building, with a 44.91% 90-day share price return and 32.88% year to date. Long-term total shareholder returns have been mixed, with a 90.84% gain over three years but a 19.08% decline over five years.

Compare Bavarian Nordic's recent momentum with hand-picked vaccine and healthcare peers by scanning our 123 healthcare AI stocks aligned with similar global health and outbreak response themes.

Bavarian Nordic now trades higher after a sharp run and a WHO-aligned role in mpox supply that looks more entrenched. Does the current valuation still leave enough upside to compensate for the risks you are taking on today?

Most Popular Narrative: 7% Undervalued

The most followed valuation narrative currently pegs Bavarian Nordic's fair value at DKK276.25, modestly above the last close at DKK256.20. This frames the recent mpox stockpile news against a company already viewed as trading below its assessed long term earnings power.

The analysts have a consensus price target of DKK276.25 for Bavarian Nordic based on their expectations of its future earnings growth, profit margins and other risk factors.

In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be DKK6.2 billion, earnings will come to DKK1.0 billion, and it would be trading on a PE ratio of 21.5x, assuming you use a discount rate of 5.7%.

See why 33 investors see Bavarian Nordic as 7% undervalued.

Result: Fair Value of DKK276.25 (UNDERVALUED)

Still, the bullish Bavarian Nordic story can unravel if chikungunya uptake keeps lagging guidance, or if Lyme and EBV timelines stretch further and dilute pipeline confidence.

Find out about the key risks to this Bavarian Nordic narrative.

Next Steps

If the mixed sentiment around Bavarian Nordic leaves you unsure, take that as a prompt to act quickly and critically evaluate both sides of the story using the 3 key rewards and 3 important warning signs.

Looking for more Bavarian Nordic style ideas?

Do not stop your research at Bavarian Nordic. Use this momentum to refresh your watchlist with fresh possibilities that match your risk and income goals.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending